Please login to the form below

Not currently logged in
Email:
Password:

Promimic appoints CEO

Magnus Larsson succeeds Ulf Brogren at the Swedish firm

Promimic Magnus LarssonGothenburg, Sweden-based Prominic, part of life science investment company Karolinska Development, has appointed Magnus Larsson as its new chief executive officer.

Larsson joins the nano-materials developer from Dentsply Sirona Implants, where he was most recently director for global market development.

He brings over 15 years of sales and marketing leadership experience in the international dental implant industry, including three years at Nobel Biocare as country manager for its Swedish business.

Tord Lendau, chairman of the board at Promimic, said: “We are pleased to welcome Magnus Larsson to the company as chief executive officer.

“Magnus brings valuable global leadership experience and a wide network from his time in the dental implant industry.”

Meanwhile, Promimic's former chief executive Ulf Brogren is relocating to the US to lead the launch of the company's North America sales operations from Austin, Texas.

Lendau added: “With this appointment and the launch of Promimic under Mr Brogren's leadership, we are now in much better position to meet our strategic commitment to our customers in North America and build our business in this important market.”

1st February 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Life Healthcare Communications

Life is a creative communications agency offering multi-channel solutions for the healthcare industry. We use a storytelling approach to turn...

Latest intelligence

Enabling market access through outcomes-based pricing
Outcomes-based pricing is a potential solution to create a link between product price and real-world outcomes, while at the same time facilitating patient access to new and innovative medicines....
Five companies 20 for 2020
20 for 2020 – Five pharma companies to watch
As a new decade gets into gear, we take a look at five pharma companies that have a lot riding on 2020...
The growing clinical importance of patient-reported outcomes (PROs)
Traditionally, the success or otherwise of medical treatments has been assessed by mortality or clinical assessments of health. However, patient self-reports of health are increasingly seen as central to the...

Infographics